Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN499724 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain (TNFRSF10D) (AA 249-263), (Intracellular) antibody
- Antibody type
- Polyclonal
- Antigen
- Human DcR2 (Intracellular Domain) Peptide (AP30280CP-N) corresponding to amino acids 249 to 263 of Human DcR2 precursor.
- Description
- Affinity Chromatography purified via peptide column
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- AA 249-263,Intracellular
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Store the antibody undiluted at 2-8°C.
Submitted references TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling.
The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.
A novel receptor for Apo2L/TRAIL contains a truncated death domain.
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.
An antagonist decoy receptor and a death domain-containing receptor for TRAIL.
The receptor for the cytotoxic ligand TRAIL.
Pan G, Ni J, Yu G, Wei YF, Dixit VM
FEBS letters 1998 Mar 6;424(1-2):41-5
FEBS letters 1998 Mar 6;424(1-2):41-5
The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.
Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA, Goodwin RG
Immunity 1997 Dec;7(6):813-20
Immunity 1997 Dec;7(6):813-20
A novel receptor for Apo2L/TRAIL contains a truncated death domain.
Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, Ashkenazi A
Current biology : CB 1997 Dec 1;7(12):1003-6
Current biology : CB 1997 Dec 1;7(12):1003-6
Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.
Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A
Science (New York, N.Y.) 1997 Aug 8;277(5327):818-21
Science (New York, N.Y.) 1997 Aug 8;277(5327):818-21
An antagonist decoy receptor and a death domain-containing receptor for TRAIL.
Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM
Science (New York, N.Y.) 1997 Aug 8;277(5327):815-8
Science (New York, N.Y.) 1997 Aug 8;277(5327):815-8
The receptor for the cytotoxic ligand TRAIL.
Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM
Science (New York, N.Y.) 1997 Apr 4;276(5309):111-3
Science (New York, N.Y.) 1997 Apr 4;276(5309):111-3
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Western blot analysis of DcR2 in HeLa whole cell lysate with AP30280PU-N DcR2 antibody at 1/1000 dilution.
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- Immunocytochemistry staining of HeLa cells using AP30280PU-N DcR2 antibody at 10?g/ml.
